Emerging therapies for cystic fibrosis lung disease.
Rubin
B K
BK
Department of Pediatrics, Wake Forest University School of Medicine, Winston-Salem, NC 27157-1081, USA. brubin@wfubmc.edu
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003550:Cystic Fibrosis / Q000150:complications / Q000473:pathology / Q000628:therapy*; D015316:Genetic Therapy; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D016040:Lung Transplantation; D012141:Respiratory Tract Infections / Q000188:drug therapy / Q000517:prevention & control
D000900:Anti-Bacterial Agents; D016756:Immunoglobulins, Intravenous